Clincosm LogoSign in Get a demo

refractory cancer

Showing 26 - 43 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Relapsed Cancer, Refractory Cancer Trial in Nashville (Animal-Assisted Interactions)

Recruiting
  • Advanced Cancer
  • +2 more
  • Animal-Assisted Interactions
  • Nashville, Tennessee
    Monroe Carell Jr Children's Hospital at Vanderbilt
May 9, 2022

Non Small Cell Lung Cancer, Advanced Cancer, Refractory Cancer Trial in Turkey (PVT-1)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Adana, Turkey
  • +3 more
May 3, 2022

Cancer, Malignancy, Refractory Cancer Trial in Singapore (Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted ?d T

Not yet recruiting
  • Cancer
  • +3 more
  • Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells (CTM-N2D)
  • Singapore, Singapore
    National University Hospital
Mar 20, 2022

Advanced Cancer, Refractory Cancer, Tumor Gastric Trial in United States (PCS6422 and capecitabine)

Recruiting
  • Advanced Cancer
  • +2 more
  • PCS6422 and capecitabine
  • Omaha, Nebraska
  • +4 more
Feb 4, 2022

Human Leukocyte Antigen Typing and Tumor Antigen Expression

Recruiting
  • Refractory Cancer
  • +3 more
    • Chicago, Illinois
    • +3 more
    Feb 14, 2022

    Cancer, Tumor, Solid, Refractory Cancer Trial in Los Angeles, Petach Tikva (TBX-3400)

    Recruiting
    • Cancer
    • +2 more
    • TBX-3400
    • Los Angeles, California
    • +1 more
    Feb 1, 2022

    Advanced Cancer, Relapsed Cancer, Refractory Cancer Trial in Nashville (Animal-Assisted Interactions)

    Active, not recruiting
    • Advanced Cancer
    • +2 more
    • Animal-Assisted Interactions
    • Nashville, Tennessee
      Monroe Carell Jr Children's Hospital at Vanderbilt
    Jan 18, 2022

    Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer Trial in Toronto (Pembrolizumab, Bendamustine Hydrochloride)

    Recruiting
    • Classical Hodgkin Lymphoma
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Dec 31, 2021

    PRecISion Medicine for Children With Cancer

    Recruiting
    • Childhood Cancer
    • +5 more
    • Molecular profiling and drug testing
    • Newcastle, New South Wales, Australia
    • +7 more
    Dec 5, 2021

    Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer Trial in United States (MPT-0118, MPT-0118 + pembrolizumab)

    Recruiting
    • Solid Tumor, Adult
    • +4 more
    • Santa Monica, California
    • +4 more
    Sep 15, 2021

    Arsenic Trioxide, p53 Mutations, Refractory Cancer Trial in Shanghai (Arsenic Trioxide)

    Recruiting
    • Arsenic Trioxide
    • +3 more
    • Arsenic Trioxide
    • Shanghai, China
      Department of Medical Oncology, Shanghai Changzheng Hospital
    Jan 4, 2021

    Wilms' Tumor, Sarcoma, Adenaocortical Carcinoma Trial run by the NCI (Tariquidar)

    Completed
    • Wilms' Tumor
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 13, 2019

    Diffuse Large B Cell Lymphoma, Primary Mediastinal (Thymic) Large B-cell Lymphoma, Transformed Indolent Lymphoma Trial in Ramat

    Unknown status
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • Bendamustine 90 mg/m2 IV on Days 1-2, Cycles 1-6
    • Ramat Gan, Israel
    • +1 more
    Apr 21, 2019

    Refractory Cancer Trial in Scottsdale, Jacksonville, Rochester (VLX600)

    Terminated
    • Refractory Cancer
    • Scottsdale, Arizona
    • +2 more
    May 3, 2018

    Refractory Cancer Trial in Beijing (Apatinib)

    Unknown status
    • Refractory Cancer
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Jun 29, 2017

    Refractory Cancer Trial in Seoul

    Unknown status
    • Refractory Cancer
      • Seoul, Gyunggido, Korea, Republic of
        Samsung Medical Center
      Aug 27, 2013

      Advanced Cancer, Refractory Cancer Trial in United States (AV-412)

      Completed
      • Advanced Cancer
      • Refractory Cancer
      • Washington, District of Columbia
      • +3 more
      Sep 30, 2011

      Refractory Cancer Trial in United States (Treatment based on Molecular Profiling)

      Completed
      • Refractory Cancer
      • Treatment based on Molecular Profiling
      • Huntsville, Alabama
      • +8 more
      Jul 9, 2009